Journal of Cell Biology and Metabolism

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Commentary - Journal of Cell Biology and Metabolism (2024) Volume 6, Issue 3

Cell Therapy: Revolutionizing Medicine with Living Cells

Shino Yu*

Department of Cancer Sciences, University of Dundee, Dundee, Uk.

*Corresponding Author:
Shino Yu
Department of Cancer Sciences
University of Dundee, Dundee, Uk.
E-mail: Yu@nih.gov

Received: 04-Jun-2024, Manuscript No. AACBM-24-138765; Editor assigned: 06-Jun-2024, PreQC No. AACBM-24-1387655(PQ); Reviewed: 20-Jun-2024, QC No AACBM-24-1387655; Revised: 22-Jun-2024, Manuscript No. AACBM-24-1387655(R); Published: 28-Jun-2024, DOI:10.35841/aacbm-6.3.215

Citation: Yu S. Cell therapy: Revolutionizing medicine with living cells. J Cell Biol Metab. 2024;6(3):215.

Visit for more related articles at Journal of Cell Biology and Metabolism

Introduction

Cell therapy is a groundbreaking field in regenerative medicine that involves the administration of living cells to replace or repair damaged tissues and treat various diseases. This innovative approach leverages the regenerative and functional capabilities of cells to restore normal function and improve patient outcomes [1]. The potential applications of cell therapy are vast, ranging from treating genetic disorders to combating degenerative diseases and enhancing wound healing. This article explores the principles, types, applications, challenges, and future prospects of cell therapy [2].

Cells used in therapy can be derived from the patient (autologous) or from a donor (allogeneic). Sources include bone marrow, peripheral blood, adipose tissue, and umbilical cord blood.

Different types of cells are used depending on the application, including stem cells, immune cells, and differentiated cells like neurons or cardiomyocytes [3].

Cells can be delivered via various methods, such as intravenous infusion, direct injection into the target tissue, or implantation of scaffolds seeded with cells.Used in bone marrow transplants to treat blood disorders like leukemia, lymphoma, and aplastic anemia [4].

Known for their ability to differentiate into bone, cartilage, and fat cells, MSCs are used in regenerative treatments for joint injuries, osteoarthritis, and cardiovascular diseases [5].

Reprogrammed from adult somatic cells to a pluripotent state, iPSCs can differentiate into any cell type, offering potential for personalized medicine and disease modeling [6].

Immune cell therapy

Chimeric antigen receptor (CAR) T-cells are genetically engineered to recognize and attack specific cancer cells. This therapy has shown remarkable success in treating certain types of leukemia and lymphoma. Dendritic cells are used to present antigens and stimulate an immune response against cancer or infectious diseases [7].

Stem cells are explored for their ability to regenerate heart tissue and improve function after myocardial infarction. Cell-based therapies enhance the healing of chronic wounds, burns, and diabetic ulcers.

HSC transplants and CAR-T cell therapies offer curative potential for leukemia, lymphoma, and myeloma. Immune cell therapies and cancer vaccines are being developed to target and eliminate solid tumors [8].

Techniques like CRISPR-Cas9 allow for the correction of genetic defects in stem cells, providing potential cures for conditions like sickle cell anemia and cystic fibrosis.

Dopamine-producing neurons derived from stem cells are investigated for their ability to restore motor function.Stem cells are explored for their potential to replace lost neurons and support brain repair [9].

Allogeneic cells can be recognized as foreign by the recipient’s immune system, leading to rejection. Strategies to mitigate this include immunosuppression and the use of genetically modified cells that are less immunogenic.

Advances in gene editing technologies like CRISPR-Cas9 allow for precise modifications of therapeutic cells, enhancing their safety and efficacy.

Combining cells with biomaterials and 3D printing techniques to create functional tissues and organs for transplantation holds the potential to address organ shortages.

These technologies can optimize cell culture conditions, predict treatment outcomes, and accelerate the development of new cell therapies.

As more cell therapies demonstrate efficacy and safety in clinical trials, regulatory approvals will increase, expanding the availability of these treatments to patients worldwide [10].

Conclusion

Cell therapy represents a transformative approach in medicine, leveraging the power of living cells to treat, repair, and regenerate tissues and organs. While challenges remain, the rapid pace of research and technological advancements promises to overcome these hurdles, paving the way for innovative therapies that can significantly improve patient outcomes. As cell therapy continues to evolve, it holds the potential to revolutionize the treatment of a wide range of diseases, offering new hope for patients and advancing the frontiers of medical science.

References

  1. Gage FH. Cell therapy. Nature. 1998;392(6679).

    2. Google Scholar

  2. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circ. 2003;107(7):929-34.

    3. Indexed at, Google Scholar, Cross Ref

  3. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451(7181):937-42.

    4. Indexed at, Google Scholar, Cross Ref

  4. Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98-103.

    5. Indexed at, Google Scholar, Cross Ref

  5. Shah NN, Fry TJ. Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol. 2019;16(6):372-85.

    6. Indexed at, Google Scholar, Cross Ref

  6. Lindvall O, Björklund A. Cell therapy in Parkinson’s disease. NeuroRx. 2004;1:382-93.

    7. Indexed at, Google Scholar, Cross Ref

  7. Kim SU, De Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res. 2009;87(10):2183-200.

    8. Indexed at, Google Scholar, Cross Ref

  8. Lipsitz YY, Timmins NE, Zandstra PW. Quality cell therapy manufacturing by design. Nat Biotechnol. 2016;34(4):393-400.

    9. Indexed at, Google Scholar, Cross Ref

  9. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7(4):204-15.

    10. Indexed at, Google Scholar, Cross Ref

  10. Malliaras K, Marban E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull. 2011;98(1):161-85.

    11. Indexed at, Google Scholar, Cross Ref

Get the App